Heartbeam Inc (BEAT)

Currency in USD
0.840
-0.041(-4.65%)
Closed·
0.843+0.003(+0.36%)
·
Earnings results expected in 8 days
BEAT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.8300.919
52 wk Range
0.5404.000
Key Statistics
Prev. Close
0.84
Open
0.888
Day's Range
0.83-0.919
52 wk Range
0.54-4
Volume
857.03K
Average Volume (3m)
1.48M
1-Year Change
-54.3478%
Book Value / Share
0.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BEAT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.375
Upside
+539.88%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Heartbeam Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 5.375
(+539.88% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
D. Boral Capital
Hold---Downgrade20-04-2026
B.Riley
Buy4.00+376.19%-New Coverage31-03-2026
D. Boral Capital
Buy5.00+495.24%-New Coverage27-03-2026
H.C. Wainwright
Buy5.50+554.76%-Maintain17-03-2026
Benchmark
Buy8.00+852.38%-Downgrade16-03-2026

Heartbeam Inc Earnings Call Summary for Q4/2025

  • HeartBeam reported Q4 2025 EPS of -$0.62, missing analyst estimates of -$0.16 by 287.5%; stock rose 8.09% to $1.39 in aftermarket trading.
  • Full-year 2025 net loss totaled $21.0M with operating cash burn under $14.0M; cash and equivalents stood at $4.4M as of December 31, 2025.
  • Company achieved FDA clearance for 12-lead synthesis software and unveiled 12-lead patch prototype, advancing its cardiac monitoring product pipeline.
  • HeartBeam projects 2026 operating cash outflows of $17M-$19M, including $3M-$5M for R&D and commercial launch investments before customer receipts.
  • Executives target cash flow breakeven at approximately 30,000 patients; exploring partnerships to accelerate commercialization in competitive market.
Last Updated: 13-03-2026, 03:58 am
Read Full Transcript

Earnings

Latest Release
12-03-2026
EPS / Forecast
-0.62 / -0.16
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BEAT Income Statement

Compare BEAT to Peers and Sector

Metrics to compare
BEAT
Peers
Sector
Relationship
P/E Ratio
−2.1x−2.4x−0.5x
PEG Ratio
−0.15−0.090.00
Price/Book
17.3x4.0x2.6x
Price / LTM Sales
-3.6x3.3x
Upside (Analyst Target)
-48.8%47.1%
Fair Value Upside
Unlock21.3%6.2%Unlock

HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart’s electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.69M3.14%1.49M
Other Institutional Investors
7.35M13.71%6.49M
Public Companies & Retail Investors
44.59M83.14%39.32M
Total
53.63M100.00%47.29M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Strome Investment Management, L.P.6.34%34,00,0002,998
The Vanguard Group, Inc.2.02%10,84,210956

FAQ

What Is the Heartbeam (BEAT) Share Price Today?

The Heartbeam share price today is 0.840.

What is the current Heartbeam (BEAT) share price and day range?

As of 05-05-2026, the Heartbeam share price is 0.840, with a previous close of 0.840. The share price has ranged from 0.830 to 0.919 today, while the 52-week range spans from 0.540 to 4.000.

What Is the Heartbeam Market Cap?

As of today, Heartbeam market cap is 45.070M.

What Is the Heartbeam (BEAT) Share Price Target?

The average 12-month share price target for Heartbeam is 5.375, with a high estimate of 8 and a low estimate of 4. 4 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +539.88% Upside potential.

What Is Heartbeam's Earnings Per Share (TTM)?

The Heartbeam EPS (TTM) is -0.623.

When Is the Next Heartbeam Earnings Date?

Heartbeam will release its next earnings report on 13-05-2026.

From a Technical Analysis Perspective, Is BEAT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Heartbeam Trade On?

Heartbeam is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Heartbeam?

The stock symbol for Heartbeam is "BEAT."

How Many Times Has Heartbeam Stock Split?

Heartbeam has split 0 times.

How Many Employees Does Heartbeam Have?

Heartbeam has 16 employees.

What Is the BEAT Premarket Price?

BEAT's last pre-market stock price is 0.893. The pre-market share volume is 20,370.000, and the stock has changed by 0.011, or 1.250%.

What Is the BEAT After Hours Price?

BEAT's last after hours stock price is 0.843, the stock has changed by 0.003, or 0.360%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.